# Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST)

> **NCT04590118** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** it-hMSC
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04590118
- **Lead sponsor:** Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-26
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-08-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04590118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04590118, "Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04590118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*